packageDacomitinib

dacomitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Dacomitinib is an EGFR tyrosine kinase inhibitor used to treat non-small-cell lung cancer. It is authorised in the European Union for this indication.

Summary written by glm-5.3-flash from Wikidata Q17130597 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:dacomitinib
ATC codes:L01EB07
DrugBank:DB11963
PubChem CID:11511120
ChEBI:132268
Wikidata:Q17130597
formula:C24H25ClFN5O2
molar mass:469.945 g/mol (PubChem CID 11511120)
logP:4.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown